Genomic Vision 

0
0
+€0,00+0% 00:00 Dnes

Štatistiky

Denné maximum
-
Denné minimum
-
52-týždňové maximum
-
52-týždňové minimum
-
Objem obchodov
-
Priem. objem
-
Trhová kap.
0
Pomer P/E
-
Dividendový výnos
-
Dividenda
-

Konkurenti

Tento zoznam je analýza založená na nedávnych trhových udalostiach. Nejde o investičné odporúčanie.

O aplikácii

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
Zobraziť viac
CEO
Mr. Aaron Bensimon
Zamestnanci
27
Krajina
Francúzsko
ISIN
FR0011799907
WKN
000A110TM

Zalistovania

0 komentárov

Podeľ sa o svoj názor

Časté otázky

Aký ticker má akcia spoločnosti Genomic Vision?▼
Ticker akcie sa môže líšiť podľa burzy. Napríklad na burze Boerse Muenchen sa akcie spoločnosti Genomic Vision obchodujú pod tickerom G09.MU.
Koľko má Genomic Vision zamestnancov?▼
Ku dňu 2. novembra 2026 má spoločnosť 27 zamestnancov.
Do akého sektora patrí Genomic Vision?▼
Genomic Vision pôsobí v sektore Health & Wellness.
Kedy spoločnosť Genomic Vision uskutočnila split akcií?▼
Spoločnosť Genomic Vision v poslednom čase neuskutočnila žiadny split akcií.
Kde má Genomic Vision sídlo?▼
Genomic Vision má sídlo v meste Bagneux, Francúzsko.